Treatment With Lenalidomide Modulates T-Cell Immunophenotype and Cytokine Production in Patients With Chronic Lymphocytic Leukemia

BACKGROUND: Lenalidomide, an immunomodulatory agent, has activity in lymphoproliferative disorders. The authors, therefore, evaluated its effects on T-cell immunophenotype and cytokine production in patients with chronic lymphocytic leukemia (CLL). METHODS: To study the immunomodulatory effects of l...

Full description

Saved in:
Bibliographic Details
Published in:Cancer
Main Authors: Lee, Bang-Ning, Gao, Hui, Cohen, Evan N., Badoux, Xavier, Wierda, William G., Estrov, Zeev, Faderl, Stefan H., Keating, Michael J., Ferrajoli, Alessandra, Reuben, James M.
Format: Artigo
Language:Inglês
Published: 2011
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4349201/
https://ncbi.nlm.nih.gov/pubmed/21858802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25983
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items